B. Riley Wealth Advisors Inc. Trims Holdings in CME Group Inc. (NASDAQ:CME)

B. Riley Wealth Advisors Inc. trimmed its stake in CME Group Inc. (NASDAQ:CME) by 11.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 3,176 shares of the financial services provider’s stock after selling 401 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in CME Group were worth $624,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Salomon & Ludwin LLC purchased a new stake in CME Group during the 1st quarter worth approximately $28,000. Y.D. More Investments Ltd purchased a new stake in CME Group during the 2nd quarter worth approximately $36,000. McClarren Financial Advisors Inc. increased its stake in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares during the period. Asset Dedication LLC increased its stake in CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares during the period. Finally, Rise Advisors LLC purchased a new stake in CME Group during the 1st quarter worth approximately $41,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Up 0.1 %

Shares of NASDAQ:CME opened at $224.43 on Friday. The stock has a market cap of $80.81 billion, a P/E ratio of 25.53, a P/E/G ratio of 8.74 and a beta of 0.55. The firm has a fifty day moving average price of $212.17 and a 200 day moving average price of $207.69. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $226.78.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. CME Group’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.30 EPS. Sell-side analysts predict that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.05%. CME Group’s payout ratio is currently 52.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CME shares. Bank of America increased their price objective on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday. Keefe, Bruyette & Woods increased their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. The Goldman Sachs Group increased their price objective on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday. Finally, JPMorgan Chase & Co. increased their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $213.77.

Insiders Place Their Bets

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.